Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bausch Health's Other Operating Expense for the
three
months ended in Jun. 2026 was MXN3,926 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was MXN17,739 Mil.
Bausch Health's quarterly Other Operating Expense
increased
from Dec. 2025 (MXN4,249 Mil) to Mar. 2026 (MXN4,923 Mil) but then
declined
from Mar. 2026 (MXN4,923 Mil) to Jun. 2026 (MXN3,926 Mil).
Bausch Health's annual Other Operating Expense
increased
from Dec. 2023 (MXN18,281 Mil) to Dec. 2024 (MXN22,462 Mil) but then
declined
from Dec. 2024 (MXN22,462 Mil) to Dec. 2025 (MXN18,024 Mil).
Bausch Health Other Operating Expense Related Terms
Bausch Health Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Bausch Health's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN17,739 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of MXN17,739 Mil mean?
Bausch Health (MEX:BHCN) has a Other Operating Expense of MXN17,739 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Bausch Health and its competitors.
Is Bausch Health's Other Operating Expense too high?
Bausch Health's current Other Operating Expense is MXN17,739 Mil. Overall, Bausch Health has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bausch Health's Other Operating Expense compare to ZTS?
Bausch Health's Other Operating Expense of MXN17,739 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Bausch Health and its competitors. Bausch Health's current Other Operating Expense is MXN17,739 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch Health stock overvalued right now?
Based on GuruFocus' analysis, Bausch Health (MEX:BHCN) is currently considered Possible Value Trap. The stock's GF Value™ is MXN128.65, compared to a current price of MXN83.00 — trading 35.5% below its estimated fair value. The current Other Operating Expense is MXN17,739 Mil. Bausch Health's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Bausch Health (MEX:BHCN), the current Other Operating Expense is MXN17,739 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bausch Health (MEX:BHCN) Overvalued in 2026?
Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued.
The current stock price of MXN83.00 is trading 35.5% below its estimated GF Value™ of MXN128.65.
GuruFocus considers Bausch Health to be Possible Value Trap.
Key valuation signals for MEX:BHCN:
Other Operating Expense: MXN17,739 Mil
GF Value™: MXN128.65 vs. price of MXN83.00 (35.5% below fair value)
No single metric tells the full story. See the MEX:BHCN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
45GF Score
Get the complete analysis for MEX:BHCN
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:BHCN has been successfully added to your 
